Drugs belonging to class 'Direct-acting antiviral'

See adverse reactions attributed to class 'Direct-acting antiviral'

Drug NameCompare
Boceprevircompare
Daclatasvircompare
Elbasvir & Grazoprevircompare
Glecaprevir & Pibrentasvircompare
Ombitasvir/Paritaprevir/Ritonavircompare
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvircompare
Simeprevircompare
Sofosbuvircompare
Sofosbuvir & Velpatasvircompare
Sofosbuvir/Velpatasvir/Voxilaprevircompare
Telaprevircompare

 

Adverse reactions attributed to entire drug class 'Direct-acting antiviral'

Please login to view adverse reactions

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top